Browning, K. N., and R. A. Travagli. Mechanism of action of baclofen in rat dorsal motor nucleus of the vagus. Am J Physiol Gastrointest Liver Physiol 280: G1106-G1113, 2001.-Using whole cell patch-clamp recordings, we investigated the effects of the GABAB receptor agonist baclofen in thin slices of rat brain stem containing identified gastric-or intestinal-projecting dorsal motor nucleus of the vagus (DMV) neurons. Perfusion with baclofen (0.1-100 M) induced a concentration-dependent outward current (EC50, 3 M) in 54% of DMV neurons with no apparent differences between gastric-and intestinal-projecting neurons. The outward current was attenuated by pretreatment with the selective GABAB antagonists saclofen and 2-hydroxysaclofen, but not by the synaptic blocker TTX, indicating a direct effect at GABAB receptors on DMV neurons. Using the selective ion channel blockers barium, nifedipine, and apamin, we showed that the outward current was due to effects on potassium and calcium currents as well as calcium-dependent potassium currents. The calcium-mediated components of the outward current were more prominent in intestinal-projecting neurons than in gastric-projecting neurons. These data indicate that although baclofen inhibits both intestinal-and gastricprojecting neurons in the rat DMV, its mechanism of action differs among the neuronal subpopulations. brain stem; electrophysiology; gastrointestinal THE DORSAL MOTOR NUCLEUS OF the vagus (DMV) contains the neurons that provide the parasympathetic efferent outflow to the subdiaphragmatic viscera (12, 22) . Afferent neurons innervating the gastrointestinal tract project to, and terminate within, the DMV either directly or via interneurons in the nucleus of the solitary tract (NTS) (2, 25, 26, 30) . DMV neurons are under inhibitory control from GABAergic neurons of the NTS (31, 32). The inhibitory actions of GABA on DMV neurons are thought to be exerted primarily by fast ionic currents mediated via GABA A receptor activation (32). Although autoradiographic studies (1, 6, 20) have demonstrated that GABA B receptors also are located throughout the dorsal vagal complex (DVC), i.e., the DMV plus the NTS, to date there is no evidence to suggest that functional GABA B receptors exist on DMV neuronal membranes.
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Functional in vivo studies have shown that subcutaneous or intracerebroventricular application of the GABA B receptor agonist baclofen increases gastric and intestinal motility (3, 10) as well as initiating vagal discharges similar to those obtained on stimulation of gastric secretion (13) . These apparently contradictory results can be explained if activation of GABA B receptors involves separate subpopulations of DVC neurons. One population would comprise excitatory DMV neurons that do not have GABA B receptors on their membrane but rather receive an inhibitory input, most likely from NTS, which is inhibited by activation of GABA B receptors. The disinhibition of these DMV neurons would result in an excitatory effect such as increase in gastric motility. Indeed, electrophysiological studies have shown that baclofen acts directly on NTS neurons to produce a membrane hyperpolarization (7) , as well as indirectly to inhibit synaptic transmission from vagal afferents (7, 23) . Another DMV neuronal population, most likely participating in inhibitory control of gastric functions, would have GABA B receptors on the membrane but would not receive inhibitory inputs containing GABA B receptors on the presynaptic membrane. The inhibition of these DMV neurons resulting from activation of GABA B receptors would reduce their inhibitory influence, causing an increase in gastric pressure. Indeed, Andrews et al. (3) hypothesized that the observed atropine-insensitive increase in gastric pressure obtained by baclofen was probably mediated via an action at a central site to reduce the tonic vagal drive to nonadrenergic noncholinergic (NANC) inhibitory neurons.
The cellular mechanisms coupled to postsynaptic GABA B receptor activation are well documented (5, 11, 14, 17, 27, 34, 35) . The mechanisms comprise activation of potassium-as well as inhibition of voltagedependent calcium conductances and adenylate cyclases.
We (8, 9) have shown recently that the DMV is composed of heterogeneous neuronal populations in terms of both membrane as well as pharmacological properties. These populations can be further distinguished based on their peripheral targets.
The aims of this study were to investigate 1) whether GABA B receptors are functionally present on the DMV membrane, and if so, 2) what the mechanism of action of the GABA B agonist baclofen is on the DMV membrane, and 3) whether there are differences in the responses of DMV neurons identified as per their peripheral projections.
METHODS
Retrograde tracing. The retrograde tracer DiI was applied to discrete gastrointestinal regions in 12-day-old SpragueDawley rat pups of either sex, as described previously (8) . Briefly, rats were anesthetized deeply with a 6% solution of halothane in accordance with the guidelines of the Animal Care and Use Committee of the University of Michigan Medical Center (Ann Arbor, MI). The depth of anesthesia (abolition of the foot pinch withdrawal reflex) was monitored before and during surgery. The abdominal area was shaved and cleaned with alcohol before a laparotomy was performed. Crystals of DiI were applied to either the major curvature of the gastric fundus or corpus, the antrum/pylorus, the duodenum (the antimesenteric surface at the level of the hepatic and pancreaticoduodenal arteries), or the minor curvature of the cecum (at the level of the ileocecal junction). The application site was embedded in a fast-hardening epoxy resin before the entire surgical area was washed with warm, sterile saline. The wound was closed with 4-0 sutures, and the animal was allowed to recover for 10-15 days.
Electrophysiology. The method used for tissue slice preparation was as described previously (32) . Briefly, rats were anesthetized deeply (halothane bubbled with air) before being killed through severing of the major blood vessels in the chest. The brain stem was removed and placed in chilled (4°C) oxygenated Krebs solution (see below for composition). Using a vibratome, we cut six to eight coronal slices containing the DMV. Slices were stored in oxygenated Krebs solution at 32°C for at least 1 h before use. A slice was then placed on a custom-made perfusion chamber (vol 500 l) and maintained at 35°C by continual perfusion with warmed oxygenated Krebs solution at a rate of 2.5 ml/min.
Retrogradely labeled neurons were identified before electrophysiological recording using a Nikon E600FS microscope fitted with DIC (Nomarski) optics and tetramethylrhodamine isothiocyanate epifluorescent filters. The brief periods of illumination required to detect the fluorescent neurons have not been observed to cause any damage (16, 21) . Once a labeled neuron was identified, electrophysiological recordings were made under bright-field illumination.
Whole cell recordings were made only from retrogradely labeled gastrointestinal-projecting neurons using patch pipettes filled with potassium gluconate solution of resistance 3-8 M⍀ (see below for composition) and a single electrode voltage-clamp amplifier (Axopatch 1D, Axon Instruments, Foster City, CA). Data were filtered at 2 kHz, digitized via a Digidata 1200C interface (Axon Instruments), and acquired and stored on an IBM personal computer using pClamp8 software (Axon Instruments). Only neurons having a series resistance (i.e., pipette ϩ access resistance) Ͻ15 M⍀ were used. A neuron was accepted for recording if it met several criteria, including a membrane stable at the holding potential that returned to baseline after the action potential afterhyperpolarization plus an action potential of at least 60 mV amplitude. The membrane potential was manually corrected for junction potential before starting each experiment. Data analysis was performed using pClamp8 software.
Drug application. Drugs were applied to the bath via a series of manually operated valves. Baclofen (10 M) was applied to all neurons to ascertain whether or not it had any effect per se before the appropriate experiment was continued. When voltage clamped at Ϫ50 mV, a minimum peak current of 20 pA had to be induced by baclofen (10 M) to classify the neuron as responsive. Drug effects were assessed with each neuron acting as its own control, i.e., the results obtained after administration of a receptor antagonist or channel blocker were compared with those obtained before administration using the paired t-test. Drugs were applied in concentrations shown previously to be effective. Results are expressed as means Ϯ SE with significance defined as P Ͻ 0.05. To minimize sampling biases, only one experiment was conducted per each brain stem slice and only one experiment of each type was conducted per animal.
Chemicals and solutions. Krebs solution was composed of (in mM): 126 NaCl, 25 NaHCO3, 2.5 KCl, 1.2 MgCl2, 2.4 CaCl 2, 1.2 NaH2PO4, and 11 dextrose, maintained at pH 7.4 by bubbling with 95%O 2-5% CO2. Intracellular solution consisted of (in mM): 128 potassium gluconate, 10 KCl, 0.3 CaCl2, 1 MgCl2, 1 HEPES, 1 EGTA, 2 ATP, and 0.25 GTP, adjusted to pH 7.35 with KOH. 1,1Ј-Dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate [DiIC 18(3) ; DiI] was purchased from Molecular Probes (Eugene, OR). R(ϩ) Baclofen and 2-hydroxysaclofen were purchased from RBI (Natick, MA). Halothane and all other drugs and chemicals were purchased from Sigma Chemical (St. Louis, MO).
RESULTS

Baclofen induces outward current in subpopulation of DMV neurons.
The effects of the GABA B receptor agonist baclofen were assessed in 394 gastrointestinalprojecting neurons of the DMV (211 gastric projecting and 187 intestinal projecting). Baclofen induced a concentration-dependent (0.1-100 M) outward current in 211 (i.e., 54%) of these neurons. No differences were observed in the magnitude of the baclofen-induced current among the gastric and intestinal groups; data were thus pooled and provided an estimated EC 50 of 3 M (Fig. 1 ). The percentage of responsive neurons did not differ between the gastric-and intestinal-projecting neurons; in fact, 112 of 211 gastric-projecting neurons (i.e., 53%) and 99 of 187 intestinal-projecting neurons (i.e., 54%) responded to perfusion with 10 M baclofen. Similarly, the distribution of the magnitude of the response to 10 M baclofen did not differ between gastric-and intestinal-projecting neurons ( Fig.  1) .
In six neurons (3 gastric and 3 intestinal), the effects of baclofen (10 M) were assessed before and after exposure to GABA B receptor antagonists. Baclofen induced a 51 Ϯ 4 pA outward current in control conditions. After perfusion with the selective antagonists saclofen (300 M, n ϭ 2) or 2-hydroxysaclofen (100 M, n ϭ 4), the baclofen-induced current was reduced to 10 Ϯ 3 pA, i.e., 17% of control (P Ͻ 0.05). However, incubation with the synaptic blocker TTX (1 M) had no effect on the baclofen-induced outward current. In fact, baclofen induced a current of 45 Ϯ 8 and 46 Ϯ 8 pA in control conditions and in the presence of TTX, respectively (n ϭ 6, 3 gastric and 3 intestinal; P Ͼ 0.05).
Baclofen effect involves several ionic conductances.
The effects of the nonselective potassium channel blocker barium (2 mM) on the outward current induced by baclofen (10 M) were assessed in 14 neurons (7 gastric and 7 intestinal). The baclofen-induced current was reduced from 66 Ϯ 14 pA in control conditions to 25 Ϯ 5 pA in the presence of barium, i.e., 41 Ϯ 3.6% of control (P Ͻ 0.05; data not shown, however, see Fig. 3 ). No significant differences were observed in the actions of barium between gastric-and intestinal-projecting neurons. In detail, barium reduced the baclofen-induced current from 73 Ϯ 24 to 25 Ϯ 7 pA in gastricprojecting neurons and from 60 Ϯ 17 to 24 Ϯ 8 pA in intestinal-projecting neurons, i.e., 41 Ϯ 5% and 41 Ϯ 6% of control in gastric-and intestinal-projecting neurons, respectively.
The effects of the L-type calcium channel blocker nifedipine (3 M) on the baclofen (10 M)-induced outward current were assessed in 34 neurons (19 gastric and 15 intestinal). The baclofen-induced current was reduced from 76 Ϯ 8.9 pA under control conditions to 40 Ϯ 4.7 pA in the presence of nifedipine, i.e., 53 Ϯ 2.4% of control (P Ͻ 0.05; data not shown, however, see Fig. 3 ). Significant differences were uncovered, however, in the magnitude of this reduction between gastric-and intestinal-projecting neurons. In gastric-projecting neurons, nifedipine reduced the baclofeninduced current from 85 Ϯ 14 to 47 Ϯ 7 pA, i.e., 58 Ϯ 3% of control, whereas in intestinal-projecting neurons, nifedipine reduced the baclofen-induced current from 66 Ϯ 9 to 32 Ϯ 6 pA, i.e., 47 Ϯ 3% of control (P Ͻ 0.05).
The involvement of both potassium and calcium conductances in mediating the actions of baclofen was confirmed by assessing the reversal potential for the baclofen-induced outward current in the absence and presence of both channel blockers. The baclofen-induced current reversed at approximately Ϫ95 mV (Fig.  2) . In the presence of barium, however, the reversal of the baclofen-induced current shifted to the more posi- Fig. 1 . Baclofen induces a concentration-dependent outward current. A: representative traces from an intestinalprojecting neuron showing that baclofen produced a concentration-dependent outward current. The cell was voltage clamped at Ϫ50 mV. The complete washout of the baclofen effect (i.e., recovery to the initial holding current) was obtained after 7-10 min (not shown). B: concentration-response curves for the baclofen-induced outward current expressed as %maximal response (Imax). The EC50 for the baclofen-response was 3 M. Data for gastric-and intestinal-projecting neurons have been pooled (n ϭ 7-34). Each neuron contributed at least 3 data points. C: relative % of the neurons tested with baclofen perfusion showed unimodal distribution of the current response. No differences were observed between gastric-and intestinal-projecting neurons at any response value.
tive value of Ϫ55 mV (n ϭ 6), i.e., further from potassium equilibrium potential (E K ). In the presence of nifedipine, however, the reversal of the baclofen-induced current shifted to the more negative value of Ϫ110 mV (n ϭ 6), i.e., closer to E K .
In eight cells (5 gastric and 3 intestinal), perfusion with barium reduced the baclofen-induced current from 68 Ϯ 21 to 26 Ϯ 6 pA, i.e., a 55 Ϯ 3.0% reduction of the baclofen-induced current; addition of nifedipine to the barium perfusate caused the baclofen-induced current to be reduced from 26 Ϯ 6 to 9 Ϯ 3 pA, i.e., 12 Ϯ 2% of the initial control value (barium vs. barium ϩ nifedipine, P Ͻ 0.05). Likewise, in nine cells (5 gastric and 4 intestinal), perfusion with nifedipine reduced the baclofen-induced current from 110 Ϯ 28 to 55 Ϯ 14 pA, i.e., a 51 Ϯ 3.7% reduction of the baclofen-induced current; addition of barium to the nifedipine perfusate caused the baclofen-induced current to be reduced from 55 Ϯ 14 to 22 Ϯ 6 pA, i.e., 19 Ϯ 3.5% of the initial control value (nifedipine vs. nifedipine ϩ barium, P Ͻ 0.05; Fig. 3) . No statistically significant differences between gastric-and intestinal-projecting neurons were observed in the total inhibition of the baclofen current by the combined antagonists.
Given that perfusion with the nonselective potassium channel blocker barium in combination with the selective calcium-L type channel antagonist nifedipine did not block the baclofen-induced outward current completely, in five neurons (3 gastric and 2 intestinal), we perfused the slice first with nifedipine alone and then in combination with the nonselective calcium channel blocker cadmium (200 M). Perfusion with nifedipine reduced the baclofen-induced current from 76 Ϯ 4 to 43 Ϯ 2 pA, i.e., a 44 Ϯ 3.9% reduction of the baclofen-induced current; addition of cadmium to the nifedipine perfusate caused the baclofen-induced current to be reduced to 34 Ϯ 4 pA, i.e, an additional 11 Ϯ 4.5% (nifedipine vs. nifedipine ϩ cadmium, P Ͻ 0.05). These data then suggested that calcium currents other than the L-type may be involved in the baclofen-induced outward current.
Because there appeared to be some overlap between the inhibitory actions of the potassium channel blocker barium and the calcium channel blocker nifedipine (i.e., 59 Ϯ 3.5% reduction by barium, 47 Ϯ 2.4% reduction by nifedipine but an 81% to 88% reduction when combined), we investigated the involvement of a calcium-dependent potassium conductance using the smallconductance potassium (SK) channel blocker apamin. The outward current induced by baclofen (10 M) was assessed before and after apamin (100 nM) in 19 neurons (12 gastric, 7 intestinal). In the presence of apamin, the baclofen-induced current was reduced from 107 Ϯ 15 to 63 Ϯ 9 pA, i.e., 62 Ϯ 3.5% of control (P Ͻ 0.05; Fig. 4A ). Differences were again apparent between gastric-and intestinal-projecting neurons. In detail, in gastric-projecting neurons, apamin reduced the baclofen-induced current from 95 Ϯ 18 to 62 Ϯ 12 pA, i.e., 68 Ϯ 4% of control, whereas in intestinalprojecting neurons, apamin reduced the baclofen-in- were voltage clamped at Ϫ50 mV and stepped to Ϫ120 mV for 800 ms every 5 s in Ϫ10-mV increments. Each data point represents an average of 6-24 neurons. In control medium, the baclofen equilibrium potential (Eb) was Ϫ95 mV (A). After perfusion with the potassium channel blocker barium (2 mM), the Eb shifted to less negative potentials (approximately Ϫ55 mV) (B). Conversely, pretreatment with the L-type calcium channel antagonist nifedipine (3 M) shifted Eb closer to potassium equilibrium potential. duced current from 126 Ϯ 26 to 63 Ϯ 15 pA, i.e., 53 Ϯ 5% of control (P Ͻ 0.05).
Because extracellular barium is not an effective blocker of calcium-dependent potassium currents (15), we tested its effects on the baclofen-induced current in combination with apamin. In 11 cells (6 gastric and 5 intestinal), perfusion with apamin decreased the baclofen-induced current from 88 Ϯ 13 to 48 Ϯ 5 pA, i.e, 60 Ϯ 5.5% of control; the addition of barium to the apamin perfusate caused the baclofen-induced current to be reduced to 24 Ϯ 3 pA, i.e., 30 Ϯ 2.5% of the initial control value (apamin vs. apamin ϩ barium, P Ͻ 0.05). Likewise, in 10 cells (5 gastric and 5 intestinal), perfusion with apamin decreased the baclofen-induced current from 136 Ϯ 21 to 79 Ϯ 15 pA, i.e., 58 Ϯ 2.8% of control; addition of nifedipine to the apamin perfusate caused the baclofen-induced current to be reduced to 57 Ϯ 12 pA, i.e., 40 Ϯ 2.4% of the initial control value (apamin vs. apamin ϩ nifedipine, P Ͻ 0.05; Fig. 4A ). No statistically significant differences between gastricand intestinal-projecting neurons were observed on the total inhibition of the baclofen current by the combined antagonists. Interestingly, though, when apamin was perfused in combination with, and after exposure to, nifedipine, a further 10 Ϯ 3.1% inhibition of the baclofen-induced current was observed in intestinal-projecting neurons. In detail, in intestinal-projecting neurons, the baclofen-induced current was reduced from 50 Ϯ 5 pA under control conditions to 30 Ϯ 6 pA in the presence of nifedipine and 25 Ϯ 5 pA in the presence of nifedipine plus apamin (n ϭ 4; P Ͻ 0.05). In gastricprojecting neurons, the baclofen-induced current was reduced from 61 Ϯ 8 pA under control conditions to 34 Ϯ 2 pA in the presence of nifedipine and 34 Ϯ 3 pA in the presence of nifedipine plus apamin (nϭ 5; P Ͼ 0.05; Fig. 4B ). These data suggested that, unlike gastric-projecting neurons, the apamin-sensitive current in intestinal-projecting neurons is activated by a combination of calcium currents rather than by the L-type calcium current only. Data are summarized in Fig. 5 .
To confirm the involvement of a calcium-dependent potassium conductance, the actions of baclofen to alter the action potential afterhyperpolarization (previously demonstrated to involve the SK-channel; Refs. 8, 24, and 29) were assessed in 20 neurons (9 gastric, 11 intestinal). Baclofen caused a 16 Ϯ 1.6% reduction in the action potential afterhyperpolarization (25 Ϯ 1.0 vs. 20 Ϯ 0.9 mV with baclofen; P Ͻ 0.05), a 42 Ϯ 4% reduction in the afterhyperpolarization rate of decay (115 Ϯ 10 vs. 62 Ϯ 4.7 ms with baclofen; P Ͻ 0.05), and an 8 Ϯ 1.6% increase in the action potential duration (2.61 Ϯ 0.14 vs. 2.82 Ϯ 0.15 ms with baclofen; P Ͻ 0.05) Fig. 5 . Summary of the effects of baclofen in the presence of ion channel antagonists. A: after incubation with barium (2 mM), nifedipine (3 M), or apamin (100 nM), the amplitude of the baclofen (10 M)-induced outward current was reduced in gastric-and intestinalprojecting DMV neurons. Note that nifedipine and apamin both produced a larger inhibition of the baclofen-induced current in intestinal compared with gastric neurons. B: in gastric-projecting neurons, nifedipine (3 M) reduced the current induced by 10 M baclofen; addition of apamin (100 nM) had no additional effect. Conversely, in intestinal-projecting neurons, addition of apamin to the nifedipine superfusate resulted in an additional decrease in the baclofen-induced current. * P Ͻ 0.05, ** P Ͻ 0.05 compared with relevant control. (data not shown). No differences were observed in the effects of baclofen on action potentials from gastric vs. intestinal neurons.
DISCUSSION
The present study provides the first direct evidence that functional GABA B receptors are located on the membrane of DMV neurons. In fact, the GABA B agonist baclofen evoked a concentration-dependent outward (inhibitory) current in a subpopulation of gastrointestinal-projecting DMV neurons via direct activation of postsynaptic GABA B receptors. The baclofen-induced outward current was mediated by several ionic conductances, namely a potassium conductance, a calcium conductance, and a calcium-dependent potassium conductance.
Although the proportion of neurons responding to baclofen and the magnitude of response were similar in gastric-and intestinal-projecting neurons, the action of baclofen, however, appeared to differ. In fact, in intestinal-projecting neurons, the calcium-mediated components of the outward current appeared to exert a more prominent role than in gastric-projecting neurons. Such differential effects provide further evidence for the nonuniformity of gastrointestinal-projecting DMV neurons (8, 9) .
In both gastric-and intestinal-projecting neurons, ϳ60% of the baclofen-induced response was mediated via activation of a barium-sensitive potassium conductance. Gastric-and intestinal-projecting neurons differed, however, in the proportion of the baclofen-induced response attributable to an effect on the inward L-type calcium conductance (42% vs. 53%, respectively; see nifedipine experiments), in the proportion of the response attributable to an effect on the apamin-sensitive calcium-dependent potassium (SK) conductance (32% vs. 48%, respectively; see apamin experiments), and in the contribution of the L-type calcium conductance to the effect on the SK conductance (100% vs. 84%, respectively; see nifedipine and apamin experiments).
Baclofen has been reported previously (14, 18, 35) to inhibit L-, N-and P/Q-type calcium channels, depending on the neuronal type investigated. For example, in rat hippocampus inhibitory neurons, baclofen inhibits L-, N-and P/Q-type calcium channels (18) , whereas in rat supraoptic nucleus neurons, baclofen inhibits only N-and P/Q-type channels (14) and in cerebellar granule cells, baclofen inhibits L-type channels (35) . Although the effects of baclofen on calcium channels other than the L-type channel were not investigated in detail in the present study, it would appear that the major proportion of the baclofen-induced inhibition of calcium channels in vagal motoneurons is mediated via inhibition of L-type calcium channels. Indeed, the combination of nifedipine and barium almost completely abolished the baclofen-induced outward current. However, after pretreatment with nifedipine alone, a small proportion of the baclofen-induced current was further inhibited by perfusion of nifedipine in combination with the nonselective calcium channel blocker cadmium. These data indicate that calcium channels other than the L-type are also affected, although such channels play a minor role in the overall baclofen response.
The present study seems to indicate differences between gastric-and intestinal-projecting neurons with regard to the source of calcium necessary to activate the apamin-sensitive calcium-dependent potassium current. In fact, the baclofen current obtained in the presence of nifedipine compared with nifedipine in combination with a supramaximal concentration of apamin (24) did not differ in gastric-projecting neurons. When the same cocktail of antagonists was tested in intestinal-projecting neurons, however, a further 10% inhibition in the baclofen-induced current was observed after pretreatment with nifedipine and apamin. These data would suggest that the apaminsensitive current in gastric-projecting neurons is fully activated by calcium entry via L-type channels, whereas in intestinal neurons sources other than the L-type calcium channels also play a role. Indeed, a different complement of voltage-dependent calcium currents has been shown to be present in rat vagal motoneurons (24, 28) , although their selective localization has not been investigated.
Although elucidating the sources of calcium necessary to activate calcium-dependent potassium currents is beyond the scope of the present study, the observed differences between gastric-and intestinal-projecting neurons are a further indication of the distinct basic characteristics of DMV neurons projecting to separate areas of the gastrointestinal tract (8, 9) .
Activation of central GABA B receptors results in several gastrointestinal effects, such as increase in gastric and intestinal motility (3, 10) , increase in gastric acid secretion (13) , increase in lower esophageal sphincter (LES) pressure (4), and decrease of glutamate-induced LES relaxation (1). A similar dichotomy, i.e., both excitatory and inhibitory central effects of baclofen, has also been seen in a recent clinical study (19) . In their work on healthy volunteers, Lidums and colleagues (19) showed that baclofen decreased the rate of transient LES relaxations, but at the same time, increased basal LES pressure, probably via a vagally mediated pathway.
To the best of our knowledge, no in vivo studies in animal models have been performed in which baclofen has been microinjected directly in the DVC while gastrointestinal effects were monitored. However, convincing evidence (1, 3, 4, 10, 13) points toward the DVC as the central site of action of baclofen on gastrointestinal function.
In an in vivo study using a ferret model, Andrews and colleagues (3) administered baclofen subcutaneously and observed an increase in gastric pressure as well as an increase in the amplitude of rhythmic contractions. Both effects were abolished by vagotomy (3). In the same study, Andrews et al. (3) reported that, in the presence of cholinergic and sympathetic blockade, the actions of baclofen were restricted to an increase in gastric corpus pressure. Such actions can be explained if one considers baclofen to have dual central effects: 1) an increase in vagal excitatory cholinergic drive to mediate the increase in rhythmic contractions and 2) a decrease in tonic vagal drive to NANC inhibitory neurons to mediate the increase in gastric pressure (3) . At the cellular level, then, such an apparent contradiction can be resolved if one assumes that the increase in vagal cholinergic drive occurs as a result of the vagal disinhibition that follows blockade of GABAergic NTS neurons impinging on DMV. On the other hand, direct inhibition of DMV neurons by baclofen would result in the relief of inhibitory NANC drive to the stomach.
Indeed, electrophysiological studies have shown that baclofen acts directly on all NTS neurons to produce a membrane hyperpolarization (7), as well as indirectly to inhibit synaptic transmission from vagal afferents (7, 23) . Such actions would relieve the tonic inhibition that the GABAergic NTS neurons exert over the DMV and lead to an increased vagal motor output (31) . Similarly, the baclofen-mediated increase in gastric acid secretion (13) can be explained by an increase in vagal activity obtained by disinhibition of NTS GABAergic neurons.
In contrast, the present study has shown that activation of GABA B receptors by baclofen is also capable of inducing a direct outward current, or membrane hyperpolarization, in a subpopulation of DMV neurons. The direct inhibition by baclofen of DMV neurons, which, in our hypothesis, control inhibitory NANC intramural neurons, provides a cellular substrate to explain the atropine-insensitive increase in gastric corpus pressure (3) and the excitatory effects on the LES (1, 4) .
In conclusion, we have shown that 1) GABA B receptors are functionally present on the membrane of a large percentage of DMV neurons, 2) activation of GABA B receptors by baclofen inhibits several ionic conductances, namely a potassium conductance, a calcium conductance, and a calcium-dependent potassium conductance; and 3) the action of baclofen appeared to differ between gastric-and intestinal-projecting neurons. In fact, in intestinal-projecting neurons, the calcium-mediated components of the outward current appeared to exert a more prominent role than in gastricprojecting neurons.
Perspectives. Our data, would then provide an explanation at the cellular level of the apparently contradictory (i.e., excitatory and inhibitory) effects of baclofen on vagal motor activity. In fact, the overall effect of brain stem GABA B receptor activation seems to be highly dependent on the neuronal circuit under study as well as the complement and activity of ionic conductances within the DMV gastrointestinal motoneurons. Future studies combining in vivo and in vitro experiments aimed at separating these circuits will be required to resolve the neurochemical phenotype and the membrane properties of the neurons involved in the effects of GABA B receptor activation in the dorsal vagal complex.
Portions of this work have been presented previously in abstract form (33) .
